Synthesis, molecular structure and evaluation of new organometallic ruthenium anticancer agents

被引：53

作者：

Camm, Kenneth D. ^{[1
]}

El-Sokkary, Ahmed ^{[1
]}

Gott, Andrew L. ^{[1
]}

Stockley, Peter G. ^{[2
]}

Belyaeva, Tamara ^{[2
]}

McGowan, Patrick C. ^{[1
]}

机构：

[1] Univ Leeds, Dept Chem, Leeds LS2 9JT, W Yorkshire, England

[2] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England

来源：

DALTON TRANSACTIONS | 2009年 / 48期

关键词：

X-RAY-STRUCTURE; ETA-6-ARENE-RUTHENIUM(II) COMPLEXES; BINDING-PROPERTIES; CRYSTAL-STRUCTURE; ARENE COMPLEXES; AMINO-ACIDS; IN-VITRO; (ETA(6)-ARENE)RUTHENIUM(II); CHEMISTRY; ANTITUMOR;

D O I：

10.1039/b918902e

中图分类号：

O61 [无机化学];

学科分类号：

070301 ; 081704 ;

摘要：

A number of new ruthenium compounds have been synthesised, isolated and characterised, which exhibit excellent cytotoxicity against a number of different human tumour cell lines including a defined cisplatin resistant cell line and colon cancer cell lines. Addition of hydrophobic groups to the ruthenium molecules has a positive effect on the cytotoxicity values. Evidence is provided that, after incubation of a ruthenium compound with a 46 mer oligonucleotide duplex and subsequent nuclease treatment, ruthenium is bound to a guanine residue.

引用

页码：10914 / 10925

页数：12

共 55 条

[1] In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer [J].

Aird, RE ;

Cummings, J ;

Ritchie, AA ;

Muir, M ;

Morris, RE ;

Chen, H ;

Sadler, PJ ;

Jodrell, DI .

BRITISH JOURNAL OF CANCER, 2002, 86 (10) :1652-1657

[2]

Aird RE, 2001, BRIT J CANCER, V85, P101

[3] [Ru(η6-p-cymene)Cl2(pta)] (pta=1,3,5-triaza-7-phosphatricyclo[3.3.1.1]decane):: a water soluble compound that exhibits pH dependent DNA binding providing selectivity for diseased cells [J].

Allardyce, CS ;

Dyson, PJ ;

Ellis, DJ ;

Heath, SL .

CHEMICAL COMMUNICATIONS, 2001, (15) :1396-1397

[4] Functionalised cyclopentadienyl zirconium compounds as potential anticancer drugs [J].

Allen, Olivia R. ;

Knox, Richard J. ;

McGowan, Patrick C. .

DALTON TRANSACTIONS, 2008, (39) :1293-1295

[5] Functionalised cyclopentadienyl titanium compounds as potential anticancer drugs [J].

Allen, Olivia R. ;

Gott, Andrew L. ;

Hartley, John A. ;

Hartley, Janet M. ;

Knox, Richard J. ;

McGowan, Patrick C. .

DALTON TRANSACTIONS, 2007, (43) :5082-5090

[6] Functionalized cyclopentadienyl titanium organometallic compounds as new antitumor drugs [J].

Allen, OR ;

Croll, L ;

Gott, AL ;

Knox, RJ ;

McGowan, PC .

ORGANOMETALLICS, 2004, 23 (02) :288-292

[7] EARLY FINDING OF PREFERRED ORIENTATION - A NEW METHOD [J].

ALTOMARE, A ;

CASCARANO, G ;

GIACOVAZZO, C ;

GUAGLIARDI, A .

JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1994, 27 :1045-1050

[8] SIR97:: a new tool for crystal structure determination and refinement [J].

Altomare, A ;

Burla, MC ;

Camalli, M ;

Cascarano, GL ;

Giacovazzo, C ;

Guagliardi, A ;

Moliterni, AGG ;

Polidori, G ;

Spagna, R .

JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1999, 32 :115-119

[9] Classical and non-classical ruthenium-based anticancer drugs: Towards targeted chemotherapy [J].

Ang, Wee Han ;

Dyson, Paul J. .

EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, 2006, (20) :4003-4018

[10] (η5-Pentamethylcyclopentadienyl)iridium(III) complexes of purine nucleobases and nucleotides:: a comparison with (η6-arene)ruthenium(II) and (η5-pentamethylcyclopentadienyl)rhodium(III) species [J].

Annen, P ;

Schildberg, S ;

Sheldrick, WS .

INORGANICA CHIMICA ACTA, 2000, 307 (1-2) :115-124

← 1 2 3 4 5 6 →